These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37671867)
21. Induced maturation of human immunodeficiency virus. Mattei S; Anders M; Konvalinka J; Kräusslich HG; Briggs JA; Müller B J Virol; 2014 Dec; 88(23):13722-31. PubMed ID: 25231305 [TBL] [Abstract][Full Text] [Related]
22. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation. Sluis-Cremer N; Arion D; Abram ME; Parniak MA Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348 [TBL] [Abstract][Full Text] [Related]
23. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication. Cherry E; Morin N; Wainberg MA AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192 [TBL] [Abstract][Full Text] [Related]
24. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo. Stewart L; Vogt VM Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375 [TBL] [Abstract][Full Text] [Related]
25. Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant. Huang M; Zensen R; Cho M; Martin MA J Virol; 1998 Mar; 72(3):2047-54. PubMed ID: 9499059 [TBL] [Abstract][Full Text] [Related]
26. Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. Jochmans D; Anders M; Keuleers I; Smeulders L; Kräusslich HG; Kraus G; Müller B Retrovirology; 2010 Oct; 7():89. PubMed ID: 20950436 [TBL] [Abstract][Full Text] [Related]
27. Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells. Stewart L; Vogt VM J Virol; 1993 Dec; 67(12):7582-96. PubMed ID: 7693975 [TBL] [Abstract][Full Text] [Related]
28. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. Shehu-Xhilaga M; Crowe SM; Mak J J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682 [TBL] [Abstract][Full Text] [Related]
29. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase. Stewart L; Vogt VM J Virol; 1991 Nov; 65(11):6218-31. PubMed ID: 1717719 [TBL] [Abstract][Full Text] [Related]
30. An Essential Role of INI1/hSNF5 Chromatin Remodeling Protein in HIV-1 Posttranscriptional Events and Gag/Gag-Pol Stability. La Porte A; Cano J; Wu X; Mitra D; Kalpana GV J Virol; 2016 Nov; 90(21):9889-9904. PubMed ID: 27558426 [TBL] [Abstract][Full Text] [Related]
31. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672 [TBL] [Abstract][Full Text] [Related]
32. Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. Huang W; Gamarnik A; Limoli K; Petropoulos CJ; Whitcomb JM J Virol; 2003 Jan; 77(2):1512-23. PubMed ID: 12502865 [TBL] [Abstract][Full Text] [Related]
33. The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site. Abram ME; Sarafianos SG; Parniak MA Retrovirology; 2010 Feb; 7():6. PubMed ID: 20122159 [TBL] [Abstract][Full Text] [Related]
34. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1. Paulus C; Ludwig C; Wagner R Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852 [TBL] [Abstract][Full Text] [Related]
35. Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its Maturation. Slack RL; Ilina TV; Xi Z; Giacobbi NS; Kawai G; Parniak MA; Sarafianos SG; Sluis Cremer N; Ishima R Structure; 2019 Oct; 27(10):1581-1593.e3. PubMed ID: 31471129 [TBL] [Abstract][Full Text] [Related]
36. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA. Liang C; Rong L; Morin N; Cherry E; Huang Y; Kleiman L; Wainberg MA J Virol; 1997 Dec; 71(12):9075-86. PubMed ID: 9371564 [TBL] [Abstract][Full Text] [Related]
38. Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1. Bleiber G; Munoz M; Ciuffi A; Meylan P; Telenti A J Virol; 2001 Apr; 75(7):3291-300. PubMed ID: 11238855 [TBL] [Abstract][Full Text] [Related]
39. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652 [TBL] [Abstract][Full Text] [Related]
40. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles. Boso G; Örvell C; Somia NV J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]